Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson’s disease
Fahim Muhammad, Yan Liu, Ningbo Wang, et al.
NeuroToxicology (2022) Vol. 93, pp. 128-139
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative α‐syn and Clearing ROS in Parkinson's Disease
Meina He, Xiangming Zhang, Ran Xia, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 16
Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
Saurabh Kumar Jha, Vinod K. Nelson, Punna Rao Suryadevara, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102386-102386
Closed Access | Times Cited: 8
Lipid Oxidation at the Crossroads: Oxidative Stress and Neurodegeneration Explored in Caenorhabditis elegans
Julia Tortajada-Pérez, Andrea del Valle Carranza, Cristina Trujillo-Del Río, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 78-78
Open Access | Times Cited: 1
Effects of Vegetal Extracts and Metabolites against Oxidative Stress and Associated Diseases: Studies in Caenorhabditis elegans
Estefani Yaquelin Hernández‐Cruz, Dianelena Eugenio-Pérez, Karla Jaqueline Ramírez-Magaña, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 8936-8959
Open Access | Times Cited: 18
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 7
A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders
Oluwadara Pelumi Omotayo, Yolandy Lemmer, Shayne Mason
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 11
Promising Tools into Oxidative Stress: A Review of Non-Rodent Model Organisms
Yuhao Zhang, Yun Li, Tianyi Ren, et al.
Redox Biology (2024) Vol. 77, pp. 103402-103402
Open Access | Times Cited: 4
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence
Luis Ángel Monsalvo-Maraver, Enid A. Ovalle-Noguez, Jade Nava-Osorio, et al.
Neurotoxicity Research (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 3
Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson’s disease
Inam Ullah, Shahab Uddin, Longhe Zhao, et al.
Experimental Brain Research (2024) Vol. 242, Iss. 4, pp. 971-986
Closed Access | Times Cited: 3
Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation
Elena Caldero-Escudero, Silvia Romero-Sanz, Sergio de la Fuente
Methods in cell biology (2024), pp. 1-34
Closed Access | Times Cited: 3
A journey through cannabidiol in Parkinson’s disease
Elaine Aparecida Del Bel, Nubia Barros-Pereira, Rafaela Ponciano de Moraes, et al.
International review of neurobiology (2024), pp. 65-93
Closed Access | Times Cited: 3
The renoprotective effects of cannabidiol on lipopolysaccharide-induced systemic inflammation model of rats
İlter İlhan, Halil Aşçı, Özlem Özmen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
Evaluation of the effects of zinc oxide (ZnO NPs) nanoparticles synthesized by green synthesis on Caenorhabditis elegans
Alper Zöngür, Simge Er Zeybekler
Biologia Futura (2024)
Closed Access | Times Cited: 2
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
Zhizhen Wang, Jonathon C. Arnold
GeroScience (2024) Vol. 46, Iss. 6, pp. 5643-5661
Closed Access | Times Cited: 2
Nicotine-mediated therapy for Parkinson’s disease in transgenic Caenorhabditis elegans model
Inam Ullah, Longhe Zhao, Shahab Uddin, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Rose essential oil diminishes dopaminergic neuron degenerations and reduces α‐synuclein aggregation in Caenorhabditis elegans models of Parkinson's disease
Fahim Muhammad, Yan Liu, Ningbo Wang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 7, pp. 2877-2893
Closed Access | Times Cited: 6
The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis
Hongyuan Lu, Qinbiao Wang, Xiaowen Jiang, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2805-2805
Open Access | Times Cited: 6
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Herbicides widely used in the world: an investigation of toxic effects on Caenorhabditis elegans
Alper Zöngür, Musa Sari
Biologia Futura (2023) Vol. 74, Iss. 1-2, pp. 171-182
Closed Access | Times Cited: 5
Therapeutic use of medical Cannabis in neurological diseases: a clinical update
Ute Hidding, Tina Mainka, Carsten Buhmann
Journal of Neural Transmission (2023) Vol. 131, Iss. 2, pp. 117-126
Open Access | Times Cited: 5
Phytocannabinoids in neuromodulation: From omics to epigenetics
Subhadip Banerjee, Debolina Saha, Rohit Sharma, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118201-118201
Closed Access | Times Cited: 1
Evaluation of the Effects of Di-(2-ethylhexyl) phthalate (DEHP) on Caenorhabditis elegans Survival and Fertility
Alper Zöngür
Applied Biochemistry and Biotechnology (2024)
Open Access | Times Cited: 1
Phytochemicals and Vitagenes for a Healthy Brain
Naomi Osakabe, Carmelina Daniela Anfuso, Ursula M. Jacob, et al.
Healthy ageing and longevity (2024), pp. 215-253
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top